Publikationen in Zusammenarbeit mit Forschern von Hospital General Universitario de Valencia (24)

2023

  1. Cardiorenal benefits of finerenone: protecting kidney and heart

    Annals of Medicine, Vol. 55, Núm. 1, pp. 502-513

  2. Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials

    The American journal of cardiology, Vol. 205, pp. 321-324

  3. Finerenone: towards a holistic therapeutic approach to patients with diabetic kidney disease

    Nefrologia, Vol. 43, Núm. 4, pp. 386-398

  4. Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis

    Journal of cardiovascular pharmacology, Vol. 81, Núm. 1, pp. 70-75

  5. The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events

    Journal of Clinical Lipidology, Vol. 17, Núm. 5, pp. 602-611

2022

  1. Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID-REAL registry

    European Journal of Clinical Investigation, Vol. 52, Núm. 12

  2. Mortality and Heart Failure Risk Reductions in Patients Treated With Sacubitril-Valsartan in Clinical Trials

    American journal of therapeutics, Vol. 29, Núm. 5, pp. e572-e575

  3. Sex Differences in Low-Density Lipoprotein Cholesterol Reduction with PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry

    Journal of Cardiovascular Pharmacology, Vol. 79, Núm. 4, pp. 523-529

2021

  1. Direct Oral Anticoagulants Versus Vitamin-K Antagonist After PCIs in Patients With AF: A Meta-analysis of Cardiac Ischemic Events

    Journal of cardiovascular pharmacology, Vol. 77, Núm. 2, pp. 164-169

  2. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

    Nature, Vol. 595, Núm. 7869, pp. 707-712

  3. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant

    Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414

2020

  1. Biofabrication of 3D tumor models in cancer research

    Biomaterials for 3D Tumor Modeling (Elsevier), pp. 67-90

2019

  1. Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors

    Revista Espanola de Cardiologia

2018

  1. Prevalence, long-term prognosis and medical alternatives for patients admitted for acute coronary syndromes and prasugrel contraindication

    International Journal of Cardiology, Vol. 270, pp. 36-41

2016

  1. Recombination in liquid-filled ionization chambers beyond the Boag limit

    Medical Physics, Vol. 43, Núm. 7, pp. 4142-4149

  2. Tendencias en factores de riesgo y tratamientos de pacientes con cardiopatía isquémica estable atendidos en consultas de cardiología entre 2006 y 2014

    Revista Espanola de Cardiologia, Vol. 69, Núm. 4, pp. 401-407

2015

  1. Clinical Practice Guideline (CPG). Recommendations on strategy for reducing risk of heart failure patients requiring noncardiac surgery: Reducing risk of heart failure patients in noncardiac surgery

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 62, Núm. 7, pp. 359-419

  2. Novedades en cardiología: Riesgo vascular y rehabilitación cardiaca

    Revista Espanola de Cardiologia, Vol. 68, Núm. 2, pp. 136-143

2014

  1. Temas de actualidad en cardiología: riesgo vascular y rehabilitación cardiaca

    Revista Espanola de Cardiologia, Vol. 67, Núm. 3, pp. 203-210

2013

  1. Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility

    PLoS ONE, Vol. 8, Núm. 9